mutations and sophisticated kar yotype. It follows a linear evolution within the CLL clone in the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding areas with the genome, are mostly situated in active promoters or enhancers, and modify the binding websites of several transcription variables